Naloxone Cloridrato Adulti Molteni (Naloxone Hydrochloride)

Naloxone, the active ingredient in Naloxone Cloridrato Adulti Molteni, is an opioid antagonist presented as a sterile solution for intramuscular, intravenous, or subcutaneous use. It rapidly reverses the effects of opioid overdose, restoring breathing and consciousness in affected individuals.

GNH USA supplies Naloxone Cloridrato Adulti Molteni as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for emergency medical services.

Naloxone is an opioid antagonist used in emergency situations to counteract opioid toxicity.

- Opioid overdose: rapid reversal of respiratory depression, sedation, and pinpoint pupils, restoring normal breathing. - Opioid‑induced respiratory depression: restores adequate ventilation in patients receiving opioid analgesia. - Opioid‑related sedation: quickly awakens patients experiencing excessive central nervous system depression due to opioids.

Naloxone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Vomiting - Sweating - Tremor - Increased blood pressure - Headache

Serious or Rare Side Effects: - Acute opioid withdrawal syndrome - Severe hypertension - Cardiac arrhythmia - Seizures - Anaphylaxis - Pulmonary edema

When using naloxone, several precautions should be observed to ensure safety and effectiveness.

- Assess patient: confirm opioid overdose before administration. - Monitor vital signs: observe respiratory rate and blood pressure after dosing. - Repeated dosing: be prepared to administer additional doses if opioid effect persists. - Pregnancy and lactation: use only if benefit outweighs risk; limited data available. - Allergic reactions: discontinue if signs of hypersensitivity appear. - Store below 25°C: keep in original packaging, protect from light and moisture.

Naloxone can interact with other medications; awareness of potential interactions helps maintain patient safety.

Major Interactions (Avoid): - High‑potency opioids: may require higher naloxone doses, increasing risk of precipitated withdrawal. - Mixed agonist‑antagonist opioids (e.g., buprenorphine): naloxone may have reduced efficacy. - Monoamine oxidase inhibitors: potential for hypertensive crisis when combined with naloxone.

Moderate Interactions (Monitor Closely): - Sedatives (benzodiazepines, barbiturates): patient may still require respiratory support after naloxone. - Cardiovascular drugs (beta‑blockers, antihypertensives): monitor blood pressure following naloxone administration. - Anticholinergic agents: may mask some withdrawal symptoms, requiring careful observation.